The Role of Selective Inhibitors of Sodium-Glucose Co-Conveyor Type 2 In Reducing of Vascular Aftereffects
Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.2117
https://www.valueinhealthjournal.com/article/S1098-3015(15)04193-5/fulltext
Section Title :
Research Podium Presentations - Session 1 and Session 2
Section Order :
1532
First Page :
A611
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04193-5&doi=10.1016/j.jval.2015.09.2117